NCT01343485

Innovative Tool to Increase Completion of Human Papillomavirus (HPV) Vaccine Series

Staying on Track: Increasing Completion of the HPV Vaccine Series With the Use of an Innovative Patient and Provider Information and Tracking Tool

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 365 (actual)
• Sponsor: Planned Parenthood Federation of America · Academic / Other
• Sex: Female
• Age: 19 Years – 26 Years
• Healthy volunteers: Accepted

Summary

Planned Parenthood Federation of America's (PPFA) Medical Affairs Division will conduct a prospective, cluster randomized trial to determine which factors influence the acquisition of the second and third human papillomavirus (HPV) vaccine doses among young women ages 19 to 26. This descriptive and interventional study will provide data to assess impact of a computerized tool upon HPV vaccine series completion. The interventional aspect of this study includes determination of patient assistance and provider support programs applicable to each woman's situation as well as the implementation of a computer software system for customized patient reminders.

Conditions

• GARDASIL Vaccination

Interventions

Type	Name	Description
BEHAVIORAL	Computer reminder system	Intervention sites will receive computer kiosk with study specific software to assist in reminding study participants to return for HPV vaccine series

Timeline

• Start date: 2011-09-01
• Primary completion: 2012-10-01
• Completion: 2012-10-01
• First posted: 2011-04-28
• Last updated: 2018-06-26
• Results posted: 2013-12-02

Locations

9 sites across 1 country: United States